Legislation Gives Feds New Tools to Target Chinese and Foreign Fentanyl Traffickers

June 28, 2019 by Sean Trambley
Legislation Gives Feds New Tools to Target Chinese and Foreign Fentanyl Traffickers

As the opioid crisis continues to devastate families and communities across the country, a new bipartisan bill, the Fentanyl Sanctions Act, promises to put more teeth in efforts to curb the activities of Chinese and other traffickers of Fentanyl and synthetic opioids.

Included in the Senate National Defense Authorization Act for Fiscal Year 2020, the bill directs the Trump administration to identify and sanction foreign traffickers of synthetic opioids on an annual basis; authorize new funding for law enforcement and intelligence agencies’ sanctions efforts; and pressure China, Mexico, and other countries to crack down on the illicit trade.

Specifically, the legislation requires the imposition of sanctions on drug manufacturers in China who knowingly provide synthetic opioids to transnational criminal organizations, like those in Mexico, who mix fentanyl with other drugs and traffic them into the U.S., and financial institutions that assist such entities. Waivers would be provided for countries that take sufficient action to implement and enforce regulations on synthetic opioid production

It also authorizes new funding to law enforcement and intelligence agencies, including the Departments of Treasury, Department of Defense and Department of State, to combat the foreign trafficking of synthetic opioids. The bill urges the President to commence diplomatic efforts with U.S. partners to establish multilateral sanctions against foreign synthetic opioid traffickers

And, the bill establishes a Commission on Synthetic Opioid Trafficking to monitor U.S. efforts and report on how to more effectively combat the flow of synthetic opioids from China, Mexico and elsewhere.

“We must hold China, currently the world’s largest producer of illicit fentanyl, accountable for its role in the trade of this deadly drug. Our Senate-passed, bipartisan sanctions bill will do just that,” said Senate Democratic Leader Chuck Schumer, D-N.Y.. “The opioid crisis has claimed tens of thousands of lives and devastated families and communities across the country. In New York state, from November 2017 to 2018, approximately 2,000 people died from an opioid overdose. About 1,500 of those deaths were from synthetic opioids like fentanyl. Our legislation is critical in this fight to save American lives, and I hope to announce soon that this bill will be signed into law.”

“The Chinese government is the world’s largest drug dealer,” said Senator Tom Cotton, R-Ark. “China has allowed fentanyl and other synthetic opioids to pour into the United States for years, killing tens of thousands of Americans. Our law enforcement and intelligence agencies need additional resources to target the fentanyl producers, traffickers, cartels, and other criminals who are funneling this poison across our borders and into our communities. I’m pleased that this year’s NDAA includes our bipartisan amendment to give law enforcement critical tools to stop this scourge and hold China accountable.”

“On average, 14 Ohioans will die every day in Ohio due to an opioid overdose,” said Senate Committee on Banking, Housing, and Urban Affairs Ranking Member Sherrod Brown, D-Ohio. “The addiction crisis has taken too many lives and caused too much devastation in Ohio. This bill will add effective new sanctions tools to help combat the flood of illicit fentanyl coming into the U.S. primarily from China and Mexico, and help provide intelligence and funding to keep these dangerous drugs out of Ohio communities.”

“There is not a single state, and not a single community, in our country that is not impacted in some way by the deadly export from China of fentanyl and its over one thousand synthetic analogues,” said Senate Committee on Banking, Housing, and Urban Affairs Chairman Mike Crapo, R-Idaho. “While China only recently agreed to the administration’s demand to prohibit all fentanyl clones through necessary regulation, this bill provides important new authorities to curb fentanyl exports by targeting those who manufacture these insidious drugs and those who facilitate or finance them. We must hold the Chinese government accountable for the fentanyl illicitly made in and exported from its country and this bill will do precisely that.”

“Fentanyl has been pouring into our country, devastating our communities every day for the past five years. In 2018 alone, a record 3,163 New Jerseyans died of opioid-related overdoses including prescription painkillers, heroin and fentanyl,” said Senate Foreign Relations Ranking Member Bob Menendez, D-N.J. “But despite our continued efforts to increase security at our ports, the fact is we need the cooperation from other countries if we’re going to have any chance at stopping this epidemic. We cannot simply take China’s word for it when they say they’ll crack down on fentanyl manufacturers—especially when American lives are at stake. With this legislation, we are sending a clear message to the Chinese government—and any other country that decides to turn a blind eye to fentanyl production—that says your actions will have consequences. I am proud to partner with my colleagues on both sides of the aisle to take this important step forward in our fight to end the scourge of opioid addiction.”

Following a commitment to the U.S. at the G-20 in December 2018, Chinese regulators announced on April 1, 2019, that a wider range of fentanyl derivatives would be declared controlled substances in China on May 1, 2019. China has struggled to enforce its current drug laws and continues to deny that its illicit fentanyl producers are a major source of the illicit opioids contributing to the U.S. opioid crisis. 

To ensure accountability, Senators Schumer, Cotton, Brown, Crapo, Menendez, Toomey, Rubio, Shaheen, Cornyn, Markey, Capito, Peters, Feinstein, and Blackburn’s sanctions legislation would pressure the Chinese government to move forward with an aggressive plan to enforce its announced new laws and provide the U.S. executive branch with flexible new sanction tools to go after actors, from manufacturers to traffickers, in China and other countries. 

Introduced by Senate Democratic Leader Chuck Schumer, D-N.Y. in April, cosponsors for the legislation include Senator Tom Cotton, R-Ark., Senate Committee on Banking, Housing and Urban Affairs Ranking Member Sherrod Brown, D-Ohio, Senate Committee on Banking, Housing, and Urban Affairs Chairman Mike Crapo, R-Idaho, Senate Committee on Foreign Relations Ranking Member Bob Menendez, D-N.J., Senator Pat Toomey, R-Pa., Senator Marco Rubio, R-Fla., Senator Jeanne Shaheen, D-N.H., Senator John Cornyn, R-Texas, Senator Ed Markey, D-Mass., Senator Shelley Moore Capito, R-W.Va., Senate Committee on Homeland Security and Governmental Affairs Ranking Member Gary Peters, D-Mich., Senate Committee on the Judiciary Ranking Member Dianne Feinstein, D-Calif, and Senator Marsha Blackburn, R-Tenn.A detailed synopsis of the bill can be found here.

A+
a-
  • China
  • Fentanyl
  • legislation
  • Mexico
  • Opioids
  • In The News

    Health

    Voting

    Health

    April 18, 2024
    by Beth McCue
    Salmonella Outbreak Linked to Fresh Basil 

    ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic... Read More

    ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic basil. As of the alert, 12 Salmonella cases in seven states have been reported. There are no reported deaths. The basil was sold at Trader Joe’s... Read More

    April 17, 2024
    by Dan McCue
    Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

    Idaho's Ban on Youth Gender-Affirming Care Has Families Desperately Scrambling for Solutions

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when... Read More

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when she began to take medication to block the onset of puberty. The gender-affirming treatment helped the now-16-year-old find happiness again, her father said. A decision by the... Read More

    Weedkiller Manufacturer Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been... Read More

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits that claim its popular weedkiller Roundup causes cancer. Nearly identical bills... Read More

    April 16, 2024
    by Dan McCue
    Agency Sets Rules Limiting Miners’ Exposure to Hazardous Silica Dust

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s... Read More

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s miners from health hazards associated with exposure to respirable crystalline silica, also known as silica dust.  Inhaling crystalline silica, a known carcinogen, can cause serious lung... Read More

    Biden Administration Announces Partnership With 50 Countries to Stifle Future Pandemics

    WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal... Read More

    WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal of preventing pandemics like the COVID-19 outbreak that suddenly halted normal life around the globe in 2020. U.S. government officials will work with the countries to develop better testing, surveillance,... Read More

    News From The Well
    scroll top